Table 3 Outcomes of CRE colonized patients compared to controls
Outcome | CRE carriers (n = 340) | Non-colonized patients (n = 679) | Univariate OR (95% CI) | P value | PS weighted OR (95% CI) | P value |
|---|---|---|---|---|---|---|
1-year mortality | 138 (40.6) | 250 (36.8) | 1.17 (0.90–1.53) | 0.243 | 0.98 (0.64–1.50) | 0.936 |
30-day mortality | 65 (19.1) | 122 (18.0) | 1.08 (0.77–1.51) | 0.655 | 0.82 (0.52–1.53) | 0.678 |
Length of stay in 1 year | 18 [14–23] | 7 [4–9] | ||||
1-year survivors (n = 631) | 18 [5–40] | 7 [2–17] | 2.05 (1.73–2.44) | < 0.001* | 1.52 (1.10–2.10) | 0.011* |
1-year non- survivors (n = 388) | 15 [6–36] | 11 [4–31] | 1.19 (0.97–1.48) | 0.102 | 0.98 (0.66–1.46) | 0.920 |
Any clinical infection | 139 (40.9) | 169 (24.6) | 2.09 (1.58–2.75) | < 0.001* | 1.65 (1.06–2.56) | 0.025* |
Any BSI | 60 (17.6) | 56 (8.3) | 2.38 (1.61–3.51) | < 0.001* | 1.98 (1.07–3.68) | 0.030* |
Enterobacterales BSI | 40 (11.8) | 36 (5.3) | 2.37 (1.48–3.80) | < 0.001* | 2.02 (0.95–4.30) | 0.069 |
CRE BSI** | 14 (4.1) | 0 (0) | – | – | ||
CRE UTI** | 13 (3.8) | 0 (0) | ||||
CRE RTI** | 7 (2.1) | 0 (0) |